Earnings Estimates

Glossary »

Stock Information

Price (Prev Close) 1,394.00
Price - 52 Week High 1,489.00
Price - 52 Week Low 838.50
Price Date (Latest) Mar 24, 2017
Median Price Target 1,500.00
Diff from Prev Close 106.00
% Difference 7.60%

Reference Information

Last Actual (FY0) 19.22
FY0 End Date Dec '16
Indicated Annual Div. N/A
Hist (5 Yr) Growth % 11.80 %
Hist (5 Yr) Stability % 165.53 %
Yield (%) N/A

 

Analyst Forecasts

Last Month Revisions
Fiscal Period Mean High Low Median # of Estimates # Up # Down Mean % Change
Annual
Dec '19
57.89 90.30 45.10 54.53 9 4 1 -0.84 %
Annual
Dec '18
35.15 45.10 24.80 33.60 10 4 3 3.28 %
Annual
Dec '17
19.62 24.40 12.28 20.03 11 6 3 8.14 %
Quarterly
Mar '17
0.00 0.00 0.00 0.00 1 0 1 N/A
Quarterly
Jun '17
3.80 3.80 3.80 3.80 1 1 0 N/A
Quarterly
Sep '17
12.10 12.10 12.10 12.10 1 1 0 N/A
Quarterly
Dec '17
2.20 2.20 2.20 2.20 1 0 1 N/A
Long Term Growth
N/A
39.40 51.70 22.30 46.00 5 1 1 29.76 %

 

Actuals

Fiscal Period Reported EPS Mean Estimates Surprise % Change
Annual
Dec '16
19.22 15.79 21.70 %
Quarterly
Mar '16
-0.19 0.23 -181.43 %
Quarterly
Jun '16
2.72 1.68 62.32 %
Quarterly
Sep '16
3.06 1.11 175.18 %
Quarterly
Dec '16
13.62 7.36 85.12 %
Annual
Dec '15
12.56 11.26 11.54 %
Annual
Dec '14
5.26 4.05 29.88 %

 

P/E Ratios

Genmab A/S - eafe hea multi-industry

Fiscal Period Genmab A/S eafe hea multi-industry Industry Relative
FY0 54.58 59.42 0.92
FY1 53.48 58.22 0.92
FY2 29.85 32.49 0.92

 

EPS Growth Rates

Genmab A/S - eafe hea multi-industry

Growth Rates Genmab A/S eafe hea multi-industry Industry Relative
FY1/FY0 2.06 2.06 1.00
FY2/FY1 79.19 79.19 1.00
FY3/FY2 64.72 64.72 1.00

Disclaimer: Mean earnings estimates are calculated by First Call based on their earnings projections made by the analysts who cover Genmab A/S. Please note that any opinions, estimates or forecasts regarding Genmab A/S's performance made by these analysts (and therefore the average estimate numbers) are theirs and do not represent opinions, forecasts or predictions of Genmab A/S or its management. Genmab A/S does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Prices are in DKK